Skip to main content

Market Overview

Applied Therapeutics Raises $69M Via Equity

  • Applied Therapeutics Inc (NASDAQ: APLTprices its underwritten public offering of 3 million at $23 per share, raising $69 million in gross proceeds, at a marginal premium of 2%.
  • Underwriters have an option to purchase up to 450,000 additional shares. The offering is expected to close by February 17.
  • APLT intends to use the net proceeds to advance clinical and preclinical development of its product candidates, prepare for commercialization and other general corporate purposes. 
  • This month, the FDA lifted the clinical hold on the company's AT-007 ACTION-Galactosemia kids pediatric study. It is expected to restart immediately. The company remains on target to submit a marketing application no later than the third quarter of 2021.
  • Goldman Sachs & Co. LLC, Cowen, and UBS Investment Bank are acting as joint book-running managers for the offering.
  • Price Action: APLT shares are trading higher by 6.93% at $25 in the premarket session on the last check Friday.

Related Articles (APLT)

View Comments and Join the Discussion!

Posted-In: Biotech News Health Care Offerings Small Cap FDA General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at